Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scleroderma Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Not applicableStudy completedNCT03207997
What this trial is testing

MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients

Who this might be right for
Scleroderma
Assistance Publique - Hôpitaux de Paris 24
Not applicableUnknownNCT04650659
What this trial is testing

Functional Exercise Tests in Patients With Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more
University of Aarhus 83
Not applicableUnknownNCT01840748
What this trial is testing

Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis

Who this might be right for
Systemic SclerosisPulmonary Hypertension
University of Paris 5 - Rene Descartes 960
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Not applicableWithdrawnNCT02278445
What this trial is testing

Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Echosense Ltd.
Not applicableLooking for participantsNCT07817160
What this trial is testing

Pelvic Floor Dysfunction in Pulmonary Systemic Sclerosis

Who this might be right for
Interstitial Lung Disease With Systemic Sclerosis
Biruni University 67
Testing effectiveness (Phase 2)Ended earlyNCT00581997
What this trial is testing

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Who this might be right for
Pulmonary Fibrosis Secondary to Systemic Sclerosis
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT03889509
What this trial is testing

A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 63
Testing effectiveness (Phase 2)Study completedNCT07542067
What this trial is testing

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Fundación Neumologica Colombiana 1
Not applicableNot Yet RecruitingNCT06615128
What this trial is testing

Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)

Who this might be right for
Assessment of Serum Level of SCD25 in RA, SSc (with or Without ILD) and IPF and Its Correlation with Disease Activity
Assiut University 66
Post-approval studies (Phase 4)UnknownNCT04928586
What this trial is testing

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 200
Not applicableNot Yet RecruitingNCT07186439
What this trial is testing

Pulmonary Hypertension Screening in Scleroderma

Who this might be right for
PHTN in Scleroderma Patients
Assiut University 35
Testing effectiveness (Phase 2)Study completedNCT02370693
What this trial is testing

Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis

Who this might be right for
Lung Diseases, InterstitialSystemic SclerosisScleroderma
Northwestern University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Not applicableStudy completedNCT03438032
What this trial is testing

Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD

Who this might be right for
Fibrosis LungSystemic Sclerosis
Northwestern University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05785065
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis With Lung InvolvementSystemic SclerosisInterstitial Lung Disease
Centre hospitalier de l'Université de Montréal (CHUM) 35
Large-scale testing (Phase 3)Study completedNCT02597933
What this trial is testing

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 580
Not applicableNot Yet RecruitingNCT07393217
What this trial is testing

Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)
Sohag University 111
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Next Page